Top compounds associated with response to SYTL1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA GSK2126458 GDSC1000 pan-cancer AAC 0.13 0.0003
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA JQ12 GDSC1000 pan-cancer AAC 0.14 0.0003
mRNA Bosutinib CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA CX-5461 GDSC1000 pan-cancer AAC 0.13 0.0004
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.13 0.0004
Download CSV